nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—ERBB4—amyotrophic lateral sclerosis	0.775	1	CbGaD
Lapatinib—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00334	0.0603	CcSEcCtD
Lapatinib—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00325	0.0586	CcSEcCtD
Lapatinib—ERBB4—embryo—amyotrophic lateral sclerosis	0.00258	0.054	CbGeAlD
Lapatinib—ERBB2—embryo—amyotrophic lateral sclerosis	0.00258	0.054	CbGeAlD
Lapatinib—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0439	CcSEcCtD
Lapatinib—ERBB4—brainstem—amyotrophic lateral sclerosis	0.00236	0.0495	CbGeAlD
Lapatinib—TAP1—medulla oblongata—amyotrophic lateral sclerosis	0.00226	0.0473	CbGeAlD
Lapatinib—PIK3C2B—medulla oblongata—amyotrophic lateral sclerosis	0.00212	0.0444	CbGeAlD
Lapatinib—TAP1—spinal cord—amyotrophic lateral sclerosis	0.00201	0.0422	CbGeAlD
Lapatinib—PIK3C2B—spinal cord—amyotrophic lateral sclerosis	0.00189	0.0396	CbGeAlD
Lapatinib—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0309	CcSEcCtD
Lapatinib—ERBB4—medulla oblongata—amyotrophic lateral sclerosis	0.00165	0.0345	CbGeAlD
Lapatinib—TAP1—cerebellum—amyotrophic lateral sclerosis	0.00159	0.0334	CbGeAlD
Lapatinib—PIK3C2B—nervous system—amyotrophic lateral sclerosis	0.00159	0.0334	CbGeAlD
Lapatinib—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00155	0.028	CcSEcCtD
Lapatinib—PI4KB—medulla oblongata—amyotrophic lateral sclerosis	0.00154	0.0323	CbGeAlD
Lapatinib—PIK3C2B—central nervous system—amyotrophic lateral sclerosis	0.00153	0.0321	CbGeAlD
Lapatinib—PIK3C2B—cerebellum—amyotrophic lateral sclerosis	0.0015	0.0314	CbGeAlD
Lapatinib—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0266	CcSEcCtD
Lapatinib—ERBB4—spinal cord—amyotrophic lateral sclerosis	0.00147	0.0308	CbGeAlD
Lapatinib—PI4KB—spinal cord—amyotrophic lateral sclerosis	0.00138	0.0288	CbGeAlD
Lapatinib—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00135	0.0243	CcSEcCtD
Lapatinib—TAP1—brain—amyotrophic lateral sclerosis	0.0013	0.0272	CbGeAlD
Lapatinib—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0233	CcSEcCtD
Lapatinib—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0232	CcSEcCtD
Lapatinib—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0232	CcSEcCtD
Lapatinib—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0228	CcSEcCtD
Lapatinib—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0226	CcSEcCtD
Lapatinib—ERBB4—nervous system—amyotrophic lateral sclerosis	0.00124	0.0259	CbGeAlD
Lapatinib—ERBB2—nervous system—amyotrophic lateral sclerosis	0.00124	0.0259	CbGeAlD
Lapatinib—PIK3C2B—brain—amyotrophic lateral sclerosis	0.00122	0.0255	CbGeAlD
Lapatinib—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00122	0.022	CcSEcCtD
Lapatinib—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0219	CcSEcCtD
Lapatinib—ERBB2—central nervous system—amyotrophic lateral sclerosis	0.00119	0.025	CbGeAlD
Lapatinib—ERBB4—central nervous system—amyotrophic lateral sclerosis	0.00119	0.025	CbGeAlD
Lapatinib—ERBB2—cerebellum—amyotrophic lateral sclerosis	0.00116	0.0244	CbGeAlD
Lapatinib—ERBB4—cerebellum—amyotrophic lateral sclerosis	0.00116	0.0244	CbGeAlD
Lapatinib—PI4KB—nervous system—amyotrophic lateral sclerosis	0.00116	0.0243	CbGeAlD
Lapatinib—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0205	CcSEcCtD
Lapatinib—PI4KB—central nervous system—amyotrophic lateral sclerosis	0.00112	0.0234	CbGeAlD
Lapatinib—PI4KB—cerebellum—amyotrophic lateral sclerosis	0.00109	0.0229	CbGeAlD
Lapatinib—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0193	CcSEcCtD
Lapatinib—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0189	CcSEcCtD
Lapatinib—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00104	0.0188	CcSEcCtD
Lapatinib—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00104	0.0188	CcSEcCtD
Lapatinib—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0184	CcSEcCtD
Lapatinib—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0183	CcSEcCtD
Lapatinib—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.001	0.0181	CcSEcCtD
Lapatinib—EGFR—cerebellum—amyotrophic lateral sclerosis	0.000987	0.0207	CbGeAlD
Lapatinib—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000971	0.0175	CcSEcCtD
Lapatinib—ERBB2—brain—amyotrophic lateral sclerosis	0.000946	0.0198	CbGeAlD
Lapatinib—ERBB4—brain—amyotrophic lateral sclerosis	0.000946	0.0198	CbGeAlD
Lapatinib—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000928	0.0168	CcSEcCtD
Lapatinib—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000899	0.0162	CcSEcCtD
Lapatinib—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000888	0.016	CcSEcCtD
Lapatinib—PI4KB—brain—amyotrophic lateral sclerosis	0.000886	0.0186	CbGeAlD
Lapatinib—Cough—Riluzole—amyotrophic lateral sclerosis	0.000876	0.0158	CcSEcCtD
Lapatinib—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000855	0.0154	CcSEcCtD
Lapatinib—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000855	0.0154	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000849	0.0153	CcSEcCtD
Lapatinib—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00082	0.0148	CcSEcCtD
Lapatinib—Infection—Riluzole—amyotrophic lateral sclerosis	0.000814	0.0147	CcSEcCtD
Lapatinib—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000804	0.0145	CcSEcCtD
Lapatinib—EGFR—brain—amyotrophic lateral sclerosis	0.000802	0.0168	CbGeAlD
Lapatinib—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000796	0.0144	CcSEcCtD
Lapatinib—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000781	0.0141	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000747	0.0135	CcSEcCtD
Lapatinib—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000741	0.0134	CcSEcCtD
Lapatinib—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000731	0.0132	CcSEcCtD
Lapatinib—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000722	0.013	CcSEcCtD
Lapatinib—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000713	0.0129	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000708	0.0128	CcSEcCtD
Lapatinib—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000707	0.0128	CcSEcCtD
Lapatinib—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000701	0.0127	CcSEcCtD
Lapatinib—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00067	0.0121	CcSEcCtD
Lapatinib—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000648	0.0117	CcSEcCtD
Lapatinib—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000604	0.0109	CcSEcCtD
Lapatinib—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000588	0.0106	CcSEcCtD
Lapatinib—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00058	0.0105	CcSEcCtD
Lapatinib—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000561	0.0101	CcSEcCtD
Lapatinib—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000521	0.00941	CcSEcCtD
Lapatinib—Rash—Riluzole—amyotrophic lateral sclerosis	0.000517	0.00933	CcSEcCtD
Lapatinib—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000516	0.00932	CcSEcCtD
Lapatinib—Headache—Riluzole—amyotrophic lateral sclerosis	0.000513	0.00927	CcSEcCtD
Lapatinib—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000487	0.00879	CcSEcCtD
Lapatinib—ABCB1—embryo—amyotrophic lateral sclerosis	0.000336	0.00704	CbGeAlD
Lapatinib—CYP2C8—brain—amyotrophic lateral sclerosis	0.000257	0.00539	CbGeAlD
Lapatinib—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000228	0.00477	CbGeAlD
Lapatinib—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000219	0.0046	CbGeAlD
Lapatinib—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000215	0.0045	CbGeAlD
Lapatinib—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000191	0.00401	CbGeAlD
Lapatinib—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000161	0.00338	CbGeAlD
Lapatinib—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000155	0.00325	CbGeAlD
Lapatinib—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000152	0.00318	CbGeAlD
Lapatinib—ABCB1—brain—amyotrophic lateral sclerosis	0.000123	0.00258	CbGeAlD
Lapatinib—EGFR—Immune System—KIFAP3—amyotrophic lateral sclerosis	6.1e-05	0.0005	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	5.99e-05	0.000491	CbGpPWpGaD
Lapatinib—EGFR—Disease—VTA1—amyotrophic lateral sclerosis	5.94e-05	0.000487	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	5.93e-05	0.000486	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	5.92e-05	0.000485	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	5.9e-05	0.000484	CbGpPWpGaD
Lapatinib—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.85e-05	0.000479	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	5.81e-05	0.000476	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.78e-05	0.000474	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	5.69e-05	0.000466	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.65e-05	0.000463	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	5.63e-05	0.000462	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	5.57e-05	0.000457	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	5.55e-05	0.000455	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	5.55e-05	0.000455	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	5.46e-05	0.000448	CbGpPWpGaD
Lapatinib—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.43e-05	0.000445	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CST3—amyotrophic lateral sclerosis	5.39e-05	0.000442	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	5.38e-05	0.000441	CbGpPWpGaD
Lapatinib—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.36e-05	0.000439	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—APOE—amyotrophic lateral sclerosis	5.34e-05	0.000437	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—amyotrophic lateral sclerosis	5.33e-05	0.000437	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CST3—amyotrophic lateral sclerosis	5.31e-05	0.000435	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	5.3e-05	0.000434	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	5.29e-05	0.000433	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	5.28e-05	0.000433	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	5.26e-05	0.000431	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—C3—amyotrophic lateral sclerosis	5.18e-05	0.000425	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VCP—amyotrophic lateral sclerosis	5.18e-05	0.000425	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—APOE—amyotrophic lateral sclerosis	5.16e-05	0.000423	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—C3—amyotrophic lateral sclerosis	5.11e-05	0.000418	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	5.09e-05	0.000417	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	5.08e-05	0.000417	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	5.02e-05	0.000411	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	4.99e-05	0.000409	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—C3—amyotrophic lateral sclerosis	4.98e-05	0.000408	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—C3—amyotrophic lateral sclerosis	4.9e-05	0.000402	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.77e-05	0.000391	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—SQSTM1—amyotrophic lateral sclerosis	4.75e-05	0.000389	CbGpPWpGaD
Lapatinib—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.71e-05	0.000386	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—IGF1—amyotrophic lateral sclerosis	4.69e-05	0.000384	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—SQSTM1—amyotrophic lateral sclerosis	4.68e-05	0.000384	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	4.67e-05	0.000383	CbGpPWpGaD
Lapatinib—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.64e-05	0.000381	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—MMP9—amyotrophic lateral sclerosis	4.6e-05	0.000377	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—amyotrophic lateral sclerosis	4.53e-05	0.000371	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	4.52e-05	0.000371	CbGpPWpGaD
Lapatinib—EGFR—Disease—CHMP2B—amyotrophic lateral sclerosis	4.5e-05	0.000369	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	4.47e-05	0.000367	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—ATF1—amyotrophic lateral sclerosis	4.46e-05	0.000365	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	4.45e-05	0.000365	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.44e-05	0.000364	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	4.4e-05	0.000361	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ATF1—amyotrophic lateral sclerosis	4.39e-05	0.00036	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.34e-05	0.000355	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	4.33e-05	0.000355	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	4.31e-05	0.000353	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CASP9—amyotrophic lateral sclerosis	4.24e-05	0.000348	CbGpPWpGaD
Lapatinib—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.2e-05	0.000344	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CASP9—amyotrophic lateral sclerosis	4.18e-05	0.000343	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	4.16e-05	0.000341	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	4.16e-05	0.000341	CbGpPWpGaD
Lapatinib—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.14e-05	0.00034	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—VEGFA—amyotrophic lateral sclerosis	4.13e-05	0.000339	CbGpPWpGaD
Lapatinib—EGFR—Disease—PLB1—amyotrophic lateral sclerosis	4.07e-05	0.000334	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	3.98e-05	0.000326	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.96e-05	0.000325	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CASP9—amyotrophic lateral sclerosis	3.92e-05	0.000321	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	3.87e-05	0.000317	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CASP9—amyotrophic lateral sclerosis	3.86e-05	0.000316	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	3.81e-05	0.000312	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—ATF1—amyotrophic lateral sclerosis	3.7e-05	0.000303	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.68e-05	0.000302	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	3.68e-05	0.000301	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.66e-05	0.0003	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.66e-05	0.0003	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—ERBB4—amyotrophic lateral sclerosis	3.63e-05	0.000298	CbGpPWpGaD
Lapatinib—EGFR—Disease—VCP—amyotrophic lateral sclerosis	3.63e-05	0.000298	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.63e-05	0.000298	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	3.61e-05	0.000296	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	3.61e-05	0.000296	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.6e-05	0.000295	CbGpPWpGaD
Lapatinib—EGFR—Immune System—DCTN1—amyotrophic lateral sclerosis	3.6e-05	0.000295	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.59e-05	0.000294	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.54e-05	0.00029	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.53e-05	0.00029	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CASP9—amyotrophic lateral sclerosis	3.52e-05	0.000289	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.47e-05	0.000284	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD40LG—amyotrophic lateral sclerosis	3.42e-05	0.00028	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	3.39e-05	0.000278	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	3.38e-05	0.000277	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD40LG—amyotrophic lateral sclerosis	3.36e-05	0.000276	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.36e-05	0.000276	CbGpPWpGaD
Lapatinib—ERBB2—Disease—ERBB4—amyotrophic lateral sclerosis	3.35e-05	0.000275	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	3.33e-05	0.000273	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	3.3e-05	0.00027	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.28e-05	0.000269	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.28e-05	0.000269	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	3.22e-05	0.000264	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	3.22e-05	0.000264	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.14e-05	0.000258	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.14e-05	0.000258	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	3.12e-05	0.000256	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.07e-05	0.000252	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.07e-05	0.000251	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—VEGFA—amyotrophic lateral sclerosis	3.06e-05	0.000251	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.05e-05	0.00025	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.03e-05	0.000248	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—C3—amyotrophic lateral sclerosis	3.02e-05	0.000247	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	3.02e-05	0.000247	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	3.01e-05	0.000247	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3e-05	0.000246	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—C3—amyotrophic lateral sclerosis	2.97e-05	0.000244	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—amyotrophic lateral sclerosis	2.95e-05	0.000242	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.95e-05	0.000242	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.94e-05	0.000241	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.9e-05	0.000237	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.88e-05	0.000236	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.88e-05	0.000236	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.87e-05	0.000236	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.85e-05	0.000234	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.84e-05	0.000233	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.79e-05	0.000228	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.79e-05	0.000228	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.78e-05	0.000228	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.74e-05	0.000225	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.74e-05	0.000224	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.72e-05	0.000223	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.7e-05	0.000222	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.68e-05	0.00022	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.67e-05	0.000219	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.61e-05	0.000214	CbGpPWpGaD
Lapatinib—EGFR—Disease—CST3—amyotrophic lateral sclerosis	2.61e-05	0.000214	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	2.6e-05	0.000213	CbGpPWpGaD
Lapatinib—ERBB2—Disease—APOE—amyotrophic lateral sclerosis	2.59e-05	0.000213	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	2.57e-05	0.000211	CbGpPWpGaD
Lapatinib—ERBB4—Disease—APOE—amyotrophic lateral sclerosis	2.56e-05	0.000209	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	2.55e-05	0.000209	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.54e-05	0.000208	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.53e-05	0.000207	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.51e-05	0.000206	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—C3—amyotrophic lateral sclerosis	2.51e-05	0.000205	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.49e-05	0.000204	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.48e-05	0.000204	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.46e-05	0.000202	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—C3—amyotrophic lateral sclerosis	2.41e-05	0.000197	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.36e-05	0.000193	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.35e-05	0.000193	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.33e-05	0.000191	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.3e-05	0.000189	CbGpPWpGaD
Lapatinib—EGFR—Immune System—SQSTM1—amyotrophic lateral sclerosis	2.3e-05	0.000188	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	2.28e-05	0.000187	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.27e-05	0.000186	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MMP9—amyotrophic lateral sclerosis	2.22e-05	0.000182	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.21e-05	0.000181	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.19e-05	0.000179	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.18e-05	0.000178	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.16e-05	0.000177	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ATF1—amyotrophic lateral sclerosis	2.15e-05	0.000177	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	2.11e-05	0.000173	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CASP9—amyotrophic lateral sclerosis	2.05e-05	0.000168	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2e-05	0.000164	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.98e-05	0.000162	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.95e-05	0.00016	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.95e-05	0.00016	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.94e-05	0.000159	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.94e-05	0.000159	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.92e-05	0.000158	CbGpPWpGaD
Lapatinib—EGFR—Disease—CASP9—amyotrophic lateral sclerosis	1.89e-05	0.000155	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.82e-05	0.000149	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.82e-05	0.000149	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.81e-05	0.000149	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.81e-05	0.000148	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.79e-05	0.000147	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTGS2—amyotrophic lateral sclerosis	1.78e-05	0.000146	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.77e-05	0.000145	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.76e-05	0.000145	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ERBB4—amyotrophic lateral sclerosis	1.76e-05	0.000144	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTGS2—amyotrophic lateral sclerosis	1.75e-05	0.000144	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.73e-05	0.000142	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.72e-05	0.000141	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.66e-05	0.000136	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD40LG—amyotrophic lateral sclerosis	1.65e-05	0.000135	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.65e-05	0.000135	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.63e-05	0.000133	CbGpPWpGaD
Lapatinib—EGFR—Disease—ERBB4—amyotrophic lateral sclerosis	1.62e-05	0.000133	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.6e-05	0.000131	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.59e-05	0.00013	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP9—amyotrophic lateral sclerosis	1.59e-05	0.00013	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.55e-05	0.000127	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.54e-05	0.000126	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.5e-05	0.000123	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.5e-05	0.000123	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.49e-05	0.000122	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.48e-05	0.000122	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.48e-05	0.000121	CbGpPWpGaD
Lapatinib—EGFR—Immune System—C3—amyotrophic lateral sclerosis	1.46e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.43e-05	0.000117	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.4e-05	0.000115	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.39e-05	0.000114	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.37e-05	0.000112	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.34e-05	0.00011	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.33e-05	0.000109	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.3e-05	0.000107	CbGpPWpGaD
Lapatinib—EGFR—Disease—APOE—amyotrophic lateral sclerosis	1.25e-05	0.000103	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.22e-05	0.0001	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.16e-05	9.53e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.16e-05	9.47e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.14e-05	9.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.14e-05	9.31e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.09e-05	8.95e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.08e-05	8.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.07e-05	8.75e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.06e-05	8.69e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.81e-06	8.04e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	9.79e-06	8.02e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.66e-06	7.92e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.44e-06	7.73e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.36e-06	7.68e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.29e-06	7.62e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.78e-06	7.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—amyotrophic lateral sclerosis	8.6e-06	7.04e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.54e-06	7e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.36e-06	6.85e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.05e-06	6.6e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	8.04e-06	6.59e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.41e-06	6.07e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.4e-06	6.06e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.3e-06	5.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.26e-06	5.95e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.19e-06	5.89e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	7.03e-06	5.76e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.01e-06	5.75e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.6e-06	5.41e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.44e-06	5.28e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	6.09e-06	4.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.59e-06	4.58e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	5.43e-06	4.45e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	5.3e-06	4.35e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.28e-06	4.33e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.82e-06	3.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.74e-06	3.89e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.32e-06	3.54e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.17e-06	3.42e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.97e-06	3.25e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.72e-06	3.05e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.63e-06	2.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.58e-06	2.94e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.27e-06	2.68e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.24e-06	1.83e-05	CbGpPWpGaD
